HIV treatment and prevention on AARP Medicare Rx Preferred from UHC (S5820-038)
Biktarvy, Dovato, Descovy and the other common HIV regimens, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), U.S. Virgin Islands
- Premium
- $114.80/month
- Deductible
- $615.00
10 of 11 HIV drugs are covered on this plan. None require prior authorization.
1 isn't on the formulary (Truvada).
- from $1,103.28Tier 5
- $813.03Tier 5
- from $630.30Tier 4
- $1,337.48Tier 5
- $1,068.64Tier 5
- $1,234.33Tier 5
- $984.53Tier 5
- from $604.54Tier 5
- from $5.19Tier 4
- from $376.05Tier 5
Not on the formulary
Truvada
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.